|
Volumn 61, Issue 10, 2001, Pages 4222-4228
|
Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MITOGEN ACTIVATED PROTEIN KINASE;
TRANSFORMING GROWTH FACTOR BETA1;
ANTIGEN ANTIBODY COMPLEX;
ARTICLE;
CANCER CELL;
CANCER INVASION;
CELL DIFFERENTIATION;
ENZYME ACTIVATION;
EPITHELIUM CELL;
GENE MUTATION;
HUMAN;
HUMAN CELL;
IMMUNOHISTOCHEMISTRY;
MESENCHYME CELL;
ONCOGENE K RAS;
PANCREAS CANCER;
PHASE CONTRAST MICROSCOPY;
PRIORITY JOURNAL;
RECEPTOR DOWN REGULATION;
CELL DIFFERENTIATION;
CELL MOVEMENT;
ENZYME ACTIVATION;
EPITHELIAL CELLS;
HUMANS;
MAP KINASE KINASE 1;
MAP KINASE SIGNALING SYSTEM;
MESODERM;
MITOGEN-ACTIVATED PROTEIN KINASE 1;
MITOGEN-ACTIVATED PROTEIN KINASE KINASES;
NEOPLASM INVASIVENESS;
PANCREATIC NEOPLASMS;
PROTEIN-SERINE-THREONINE KINASES;
RAS PROTEINS;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA1;
TUMOR CELLS, CULTURED;
|
EID: 0035872426
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (327)
|
References (37)
|